IGC logo
  • NYSE American: IGC
  • About
    • Company’s Overview
    • Our Team
  • Cannabinoids
    • Overview
    • Cannabis Industry Outline
    • Cannabinoid Receptors
    • THC and CBD
    • Strategic Partnerships
    • Pain Relief
    • Medical Refractory Epilepsy
    • Eating Disorders
    • Dogs and Cats
  • Alzheimer’s Disease
  • Investor Center
    • Overview
    • Press Releases
    • SEC Filings
  • Contact
49 posts, 0 comments
IGC

November 20, 2017Rohit
Subscribe Now #mc_embed_signup{background:#fff; clear:left; font:14px Helvetica,Arial,sans-serif; } /* Add your own MailChimp form style overrides in your site stylesheet or in this style block. We recommend moving this block and the preceding CSS link to the HEAD of your HTML file. */ * indicates required Email Address * First Name Last Name Phone Number (function($)...
IGC Investor

Investor’s Overview

November 20, 2017Rohit
Investor's FAQQ: What are the investment highlights? Q: What is the stock symbol for the Company and where is it listed? Q: Tell me about the warrants. Q: Where is IGC incorporated? Q: Who does IGC use for clearing its stock? Q: How do I obtain the latest annual report? Q: What is IGC's financial...
Cannabinoid Receptor

Cannabinoid Receptors

November 20, 2017Rohit
Discovery The cannabis plant has been used for centuries; however, the psychotropic compound responsible for the reported “high”, tetrahydrocannabinol (THC), was isolated in 1964. It is now believed that this hydrophobic compound works on a distinct family of receptors in the brain and other tissues. The first of these receptors were discovered in 1988 using...
IGC

Dogs and Cats

November 20, 2017Rohit
Convulsions Seizures in dogs and cats are often caused by abnormal brain activity. They can be subtle or cause violent convulsions. Some seizures only occur once, but repeated seizures require treatment to prevent larger areas of the brain from becoming affected. Our Strategy IGC has applied for a U.S patent based on a novel therapy...
IGC

Eating Disorders

November 20, 2017Rohit
About 1.3 million humans in the United States are affected each year by Cachexia, which is a weakness and wasting away of the body due to severe illnesses such as cancer, multiple sclerosis, Parkinson’s disease, HIV/AIDS and other progressive diseases.  Cachexia is secondary to an underlying disease such as cancer or AIDS and is a...
IGC

Medical Refractory Epilepsy

November 20, 2017Rohit
Drug Resistant Epilepsy Refractory Epilepsy or Drug Resistant Epilepsy typically refers to Epilepsy wherein a person has failed to become seizure free with adequate trials of two seizure medications. About 50 million people worldwide are affected by Epilepsy (Sander, 2003). Epilepsy is due to multiple factors including Sodium, Potassium, GABA and NMDA. Modulating one or...
IGC Pain Relief

Pain Relief

November 20, 2017Rohit
Cost Of Pain Health economists writing in The Journal of Pain in September 2012 reported that the annual estimated national cost of pain ranges from $560 billion to $635 billion, which is more than the cost of the nation’s priority health conditions. Debilitating Pain The treatment of pain is a great challenge for health care...
IGC Strategic Partnership

Strategic Partnerships

November 20, 2017Rohit
Producers, Processors, Dispensaries We are interested in licensing our products to processors in medical states in the U.S. We are also interested in partnering with Canadian growers and processors to market our products in Canada as well as exporting to Europe. If you are an interested grower, processor, dispensary in the U.S., or in Canada,...

THC and CBD

November 20, 2017Rohit
Strains Cannabis is grown in many strains. Each strain has a different level or ratio of cannabinoids that are a class of compounds that act on the cannabinoid receptors. Phytocannabinoids are naturally occurring cannabinoids found in the cannabis plant. There are over 60 different cannabinoids that have been isolated from the cannabis plant that exhibit...
IGC Cannabis History

Cannabis Industry Outline

November 20, 2017Rohit
Cannabis History An understanding of the subspecies of the cannabis plant is imperative for a well-rounded comprehension of the history of cannabis and the role it plays in today’s modern era. Cannabis sativa, often described as “marijuana,” has psychoactive properties. On the contrary, Cannabis sativa L., commonly referred to as “hemp,” is a non-psychoactive form of cannabis. Further psychoactive...

Posts navigation

< 1 2 3 4 5 >

Management

  • Ram Mukunda, CEO
  • Dr. Jagadeesh Rao, Scientific Officer
  • Claudia Grimaldi, General Manager
  • Rohit Goel, Co-PAO

Advisors

  • Dr. Chuanhai Cao
  • Dr. Ranga Krishna
  • Dr. James A. Saunders
  • Jack Lynch
  • Dr. Carolina Gutierrez de Piñeres
  • Dr. Craig Cheifetz
  • Chua Seong Seng
  • Carrolee Barlow

Board of Directors

  • Richard Prins, Chairman
  • Sudhakar Shenoy, Director

Contacts

IGC PO BOX 60642 Potomac, Maryland 20859-0642 USA
(301) 983 0998
(240) 465 0273
info@igcinc.us

Connect with us

Email
Facebook
Twitter
LinkedIn

Select Language

en English
en Englishes Spanish
Copyright NoticeDisclaimerTerms and ConditionsPrivacy Policy
@2017 India Globalization Capital Inc. All rights reserved